Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 6 minute read Metals and Mining Industry News Glencore (LSE: GLEN) preliminary results 2025: Why copper momentum, not headline EBITDA, is driving the investment case Glencore plc’s 2025 results reveal a copper-led strategy shift. Find out why second-half momentum matters more than headline EBITDA today. byVenkateshFebruary 18, 2026